1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Substance Withdrawal Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adam, K; Oswald, I | 1 |
Jakowec, DM; Neiman, J; Packham, MA; Rand, ML | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Substance Withdrawal Syndrome
Article | Year |
---|---|
Possible mechanism for adverse reactions to triazolam.
Topics: Alprazolam; Anxiety; Humans; Platelet Activating Factor; Receptors, GABA-A; Substance Withdrawal Syndrome; Triazolam | 1991 |
Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal.
Topics: Adult; Aged; Alcoholism; Blood Platelets; Calcium; Ethanol; Female; Hemorrhagic Disorders; Humans; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Serotonin; Smoking; Stimulation, Chemical; Substance Withdrawal Syndrome; Thromboxane B2 | 1989 |